Please login to the form below

Not currently logged in
Email:
Password:

Syncona

This page shows the latest Syncona news and features for those working in and with pharma, biotech and healthcare.

$450m diagnostics sale will fuel more Syncona biotech funding

$450m diagnostics sale will fuel more Syncona biotech funding

Radiopharmaceuticals firm sold to Braco Imaging. Syncona has sold off its innovative diagnostics company Blue Earth Imaging to Bracco Imaging for $450m (£354.3m). ... owner will continue to develop the business through its next chapter,” said Martin

Latest news

More from news
Approximately 5 fully matching, plus 4 partially matching documents found.

Latest Intelligence

  • 25 Women Leaders in UK Healthcare (part 2) 25 Women Leaders in UK Healthcare (part 2)

    After a merger with fellow Syncona stablemate Orbit, Soraya has taken on the R&D lead role, charged with developing and eventually gaining approval for its lead investigational gene therapy, GT005

  • European venture funding for the life science sector European venture funding for the life science sector

    New funds such as Oxford Sciences Innovation, Syncona (which listed at the start of the year and consequently increased its deployment capital) are likely to reinforce this trend going forward. ... The recent flotation of Syncona’s Nightstar

  • Pharma deals during January 2013 Pharma deals during January 2013

    in this vein this year, the Wellcome Trust announced the investment of $200m initial capital into Syncona Partners LLP a new evergreen investment company. Syncona will make investments across healthcare – device, ... Acquisition. Contraception

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest appointments

  • Gyroscope Therapeutics appoints CEO Gyroscope Therapeutics appoints CEO

    team. Chris Hollowood, chairman of the board and chief investment office at Syncona, said: “We are extremely pleased to appoint Soraya and look forward to her leadership and extensive gene therapy

  • Anne Prener to lead Freeline Therapeutics Anne Prener to lead Freeline Therapeutics

    Chris Hollowood, chairman of Freeline Therapeutics and chief investment officer of Syncona, said: “Anne is an extremely accomplished executive with extensive experience in building and leading teams and developing haematology and

  • Edward Hodgkin elected chair of UK biotech association Edward Hodgkin elected chair of UK biotech association

    Hodgkin is currently a partner at the Wellcome Trust's independent subsidiary Syncona Partners, where his role is to create and lead new life science ventures.

More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
integrated medhealth communication

imc group is a leading, independent global healthcare communication group that enables client’s brands to connect with healthcare professionals, payers...

Latest intelligence

Top 10 ways that Medical Affairs teams can leverage the Impetus InSite Platform®
Some of the most popular and innovative ways of using our cutting-edge asynchronous and synchronous virtual tools for Medical Affairs teams....
The power of communication: Engaging diverse groups in healthcare
Humans are diverse and communications to engage us need to be inclusive. It’s no longer about talking to a group, a cohort or an imagined section of society - especially...
Building the hospital of the future
Senior Consultant Leah Carlisle explores the growing trend of virtual hospitals and what it takes to develop a holistic digital ecosystem centered on the ultimate patient experience....